Dr. Suzanne Vernon and Mark Stone described the Association’s venture philanthropy model of being a convener, connector and collaborator to move promising discoveries through the drug development process, keeping the patient as our central focus every step of the way.

Learn more about other webinars in the series and our special patient-focused survey. We’ll use all the responses submitted by April 17 in the analysis for the FDA meeting; the survey will stay open indefinitely to continue collecting information from as large a group of stakeholders as possible. Thank you to 1,170+ people who have started or completed the survey so far.

We look forward to your participation!

We make every effort to record our webinar programs and post the recordings on our YouTube channel for those unable to attend the live event and for later reference.

*We use the term ME/CFS to refer to conditions also known as chronic fatigue syndrome, CFS, myalgic encephalomyelitis, myalgic encephalopathy, ME and by other names.